Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
131.60    1.00 (0.77%)
Bid:
131.20
Ask:
131.40
Spread: 0.20 (0.152%)
Market Cap: £269.90m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

2023 Trading Update

24 Jan 2024 07:00

RNS Number : 6815A
Forterra plc
24 January 2024
 

24 January 2024

FORTERRA PLC

 

2023 Trading Update

 

Adjusted EBITDA expected to be slightly ahead of the Board's previous expectations

 

Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides its trading update for the year ended 31 December 2023.

 

Trading

 

· Full year revenue totalled c.£345m (2022: £455m), a year-on-year reduction of c.24%, with the impact of falling sales volumes partially offset by pricing benefits.

 

· Despite weak demand, pricing across our range of products remains resilient with modest 2024 price increases recently communicated.

 

· Figures published by the Department of Business and Trade highlight that UK brick despatches in the three-month period to November were 33% lower than the equivalent period in 2022, taking the cumulative YTD reduction to approximately 30%. As highlighted previously, our own despatches fell by a greater percentage driven by our exposure to volume housebuilding which suffered the greatest impact from rising interest rates.

 

· Despite continued challenging market conditions we expect to report full year adjusted EBITDA slightly ahead of the Board's expectations.

 

Management Actions

 

· Strong management actions during the year will deliver annualised fixed costs savings in excess of £20m with around £6m realised in 2023 with the balance in 2024. One-off cash restructuring costs are expected to total £9m of which £4m will be paid in 2024.

 

· Faced with increasing inventory levels, we made further reductions to production during the second half of 2023 which, assuming 2024 demand remains consistent with 2023, will ensure output is aligned with sales.

 

· Production has been reduced through the mothballing of factories, shift reductions and production breaks. In addition, we have delivered further savings through restructuring commercial and back-office functions.

 

· These temporary reductions will not impact our ability to respond quickly when our markets recover, with the new Desford brick factory also providing us with a significant capacity uplift.

 

Balance Sheet

 

· Reflecting our inventory build, capital expenditure and the management actions taken during 2023, year-end net debt before leases is expected to be c.£95m.

 

Outlook

 

· The outlook for our industry remains subject to considerable uncertainty and, with a general election expected in 2024, demand is anticipated to remain subdued in the near term.

 

· However, with the long term under supply of housing in the UK continuing to worsen, and UK brick despatches now running at levels last seen in 2009, the Board remains confident in the Group's ability to benefit as our key markets recover.

 

· Recent reductions in mortgage interest rates will improve the affordability of new homes, thus increasing demand for our products.

 

· The Group intends to announce its FY23 results on 26 March 2024.

 

 

ENQUIRIES

 

 

Forterra plc

+44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting

+44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOVWRSWUAUAR
Date   Source Headline
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase
2nd Nov 20228:45 amRNSDirector Declaration
31st Oct 20225:01 pmRNSTotal Voting Rights
31st Oct 20222:54 pmRNSDirector/PDMR Shareholding
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSTransaction in Own Shares
6th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20226:26 pmRNSEmployee Benefit Trust Share Purchase
4th Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20225:40 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.